Adult population age > 30 years old who are diagnosed with rheumatoid arthritis with tumor necrosis factor-alpha inhibitors as part of current medication regime either solitary or in combination with other disease-modifying antirheumatic drugs. Here, TNF is linked to rheumatoid arthritis.